197 related articles for article (PubMed ID: 22022577)
1. Nuclear GRP75 binds retinoic acid receptors to promote neuronal differentiation of neuroblastoma.
Shih YY; Lee H; Nakagawara A; Juan HF; Jeng YM; Tsay YG; Lin DT; Hsieh FJ; Pan CY; Hsu WM; Liao YF
PLoS One; 2011; 6(10):e26236. PubMed ID: 22022577
[TBL] [Abstract][Full Text] [Related]
2. Nuclear RXRα and RXRβ receptors exert distinct and opposite effects on RA-mediated neuroblastoma differentiation.
Girardi CS; Rostirolla DC; Lini FJM; Brum PO; Delgado J; Ribeiro CT; Teixeira AA; Peixoto DO; Heimfarth L; Kunzler A; Moreira JCF; Gelain DP
Biochim Biophys Acta Mol Cell Res; 2019 Mar; 1866(3):317-328. PubMed ID: 30529222
[TBL] [Abstract][Full Text] [Related]
3. Distinct sensitivity of neuroblastoma cells for retinoid receptor agonists: evidence for functional receptor heterodimers.
Carpentier A; Balitrand N; Rochette-Egly C; Shroot B; Degos L; Chomienne C
Oncogene; 1997 Oct; 15(15):1805-13. PubMed ID: 9362447
[TBL] [Abstract][Full Text] [Related]
4. Identification of GRP75 as an independent favorable prognostic marker of neuroblastoma by a proteomics analysis.
Hsu WM; Lee H; Juan HF; Shih YY; Wang BJ; Pan CY; Jeng YM; Chang HH; Lu MY; Lin KH; Lai HS; Chen WJ; Tsay YG; Liao YF; Hsieh FJ
Clin Cancer Res; 2008 Oct; 14(19):6237-45. PubMed ID: 18829503
[TBL] [Abstract][Full Text] [Related]
5. Differential changes of retinoid-X-receptor (RXR alpha) and its RAR alpha and PML-RAR alpha partners induced by retinoic acid and cAMP distinguish maturation sensitive and resistant t(15;17) promyelocytic leukemia NB4 cells.
Duprez E; Lillehaug JR; Gaub MP; Lanotte M
Oncogene; 1996 Jun; 12(11):2443-50. PubMed ID: 8649786
[TBL] [Abstract][Full Text] [Related]
6. Retinoic acid induces differentiation in neuroblastoma via ROR1 by modulating retinoic acid response elements.
Illendula A; Fultang N; Peethambaran B
Oncol Rep; 2020 Sep; 44(3):1013-1024. PubMed ID: 32705280
[TBL] [Abstract][Full Text] [Related]
7. Dihydropyrimidinase-like protein 3 expression is negatively regulated by MYCN and associated with clinical outcome in neuroblastoma.
Tan F; Wahdan-Alaswad R; Yan S; Thiele CJ; Li Z
Cancer Sci; 2013 Dec; 104(12):1586-92. PubMed ID: 24011394
[TBL] [Abstract][Full Text] [Related]
8. MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma.
Lovén J; Zinin N; Wahlström T; Müller I; Brodin P; Fredlund E; Ribacke U; Pivarcsi A; Påhlman S; Henriksson M
Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1553-8. PubMed ID: 20080637
[TBL] [Abstract][Full Text] [Related]
9. Expression of retinoid receptors during the retinoic acid-induced neuronal differentiation of human embryonal carcinoma cells.
Cheung WM; Chu PW; Lung CH; Ip NY
J Neurochem; 2000 Jul; 75(1):34-40. PubMed ID: 10854244
[TBL] [Abstract][Full Text] [Related]
10. Expression and activation of nuclear hormone receptors result in neuronal differentiation and favorable prognosis in neuroblastoma.
Sainero-Alcolado L; Mushtaq M; Liaño-Pons J; Rodriguez-Garcia A; Yuan Y; Liu T; Ruiz-Pérez MV; Schlisio S; Bedoya-Reina O; Arsenian-Henriksson M
J Exp Clin Cancer Res; 2022 Jul; 41(1):226. PubMed ID: 35850708
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid induced downregulation of MYCN is not mediated through changes in Sp1/Sp3.
Kanemaru KK; Tuthill MC; Takeuchi KK; Sidell N; Wada RK
Pediatr Blood Cancer; 2008 Apr; 50(4):806-11. PubMed ID: 17554788
[TBL] [Abstract][Full Text] [Related]
12. Vasoactive intestinal peptide decreases MYCN expression and synergizes with retinoic acid in a human MYCN-amplified neuroblastoma cell line.
Chevrier L; Meunier AC; Cochaud S; Muller JM; Chadéneau C
Int J Oncol; 2008 Nov; 33(5):1081-9. PubMed ID: 18949372
[TBL] [Abstract][Full Text] [Related]
13. A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins.
Zhong S; Delva L; Rachez C; Cenciarelli C; Gandini D; Zhang H; Kalantry S; Freedman LP; Pandolfi PP
Nat Genet; 1999 Nov; 23(3):287-95. PubMed ID: 10610177
[TBL] [Abstract][Full Text] [Related]
14. Low expression of Wnt-5a gene is associated with high-risk neuroblastoma.
Blanc E; Roux GL; Bénard J; Raguénez G
Oncogene; 2005 Feb; 24(7):1277-83. PubMed ID: 15592517
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RARalpha) and oncogenic RARalpha fusion proteins.
Zhu J; Gianni M; Kopf E; Honoré N; Chelbi-Alix M; Koken M; Quignon F; Rochette-Egly C; de Thé H
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14807-12. PubMed ID: 10611294
[TBL] [Abstract][Full Text] [Related]
16. High glucose-induced repression of RAR/RXR in cardiomyocytes is mediated through oxidative stress/JNK signaling.
Singh AB; Guleria RS; Nizamutdinova IT; Baker KM; Pan J
J Cell Physiol; 2012 Jun; 227(6):2632-44. PubMed ID: 21882190
[TBL] [Abstract][Full Text] [Related]
17. p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomas.
Dreidax D; Bannert S; Henrich KO; Schröder C; Bender S; Oakes CC; Lindner S; Schulte JH; Duffy D; Schwarzl T; Saadati M; Ehemann V; Benner A; Pfister S; Fischer M; Westermann F
Hum Mol Genet; 2014 Dec; 23(25):6826-37. PubMed ID: 25104850
[TBL] [Abstract][Full Text] [Related]
18. Specific retinoid receptors cooperate to signal growth suppression and maturation of human embryonal carcinoma cells.
Spinella MJ; Kitareewan S; Mellado B; Sekula D; Khoo KS; Dmitrovsky E
Oncogene; 1998 Jul; 16(26):3471-80. PubMed ID: 9692555
[TBL] [Abstract][Full Text] [Related]
19. Transcription factor activating protein 2 beta (TFAP2B) mediates noradrenergic neuronal differentiation in neuroblastoma.
Ikram F; Ackermann S; Kahlert Y; Volland R; Roels F; Engesser A; Hertwig F; Kocak H; Hero B; Dreidax D; Henrich KO; Berthold F; Nürnberg P; Westermann F; Fischer M
Mol Oncol; 2016 Feb; 10(2):344-59. PubMed ID: 26598443
[TBL] [Abstract][Full Text] [Related]
20. The MYCN inhibitor BGA002 restores the retinoic acid response leading to differentiation or apoptosis by the mTOR block in MYCN-amplified neuroblastoma.
Lampis S; Raieli S; Montemurro L; Bartolucci D; Amadesi C; Bortolotti S; Angelucci S; Scardovi AL; Nieddu G; Cerisoli L; Paganelli F; Valente S; Fischer M; Martelli AM; Pasquinelli G; Pession A; Hrelia P; Tonelli R
J Exp Clin Cancer Res; 2022 Apr; 41(1):160. PubMed ID: 35490242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]